BioXcel Therapeutics, Inc. (BTAIQ)
OTC: BTAIQ · CIK 0001720893 · United States
Every official BioXcel Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open BTAIQ filings
BioXcel Therapeutics, Inc. documents
- BioXcel Therapeutics, Inc. 10-K 2026BTAIQ 10-K 2026: annual report for fiscal 2026
- BioXcel Therapeutics, Inc. 10-K 2025BTAIQ 10-K 2025: annual report for fiscal 2025
- BioXcel Therapeutics, Inc. 10-K 2024BTAIQ 10-K 2024: annual report for fiscal 2024
- BioXcel Therapeutics, Inc. 10-K 2023BTAIQ 10-K 2023: annual report for fiscal 2023
- BioXcel Therapeutics, Inc. 10-K 2022BTAIQ 10-K 2022: annual report for fiscal 2022
- BioXcel Therapeutics, Inc. 10-Q 2026BTAIQ 10-Q 2026: quarterly report for fiscal 2026
- BioXcel Therapeutics, Inc. 10-Q 2025BTAIQ 10-Q 2025: quarterly report for fiscal 2025
- BioXcel Therapeutics, Inc. 10-Q 2024BTAIQ 10-Q 2024: quarterly report for fiscal 2024
- BioXcel Therapeutics, Inc. 10-Q 2023BTAIQ 10-Q 2023: quarterly report for fiscal 2023
- BioXcel Therapeutics, Inc. 10-Q 2022BTAIQ 10-Q 2022: quarterly report for fiscal 2022
- BioXcel Therapeutics, Inc. 8-K 2026BTAIQ 8-K 2026: current report for fiscal 2026
- BioXcel Therapeutics, Inc. 8-K 2025BTAIQ 8-K 2025: current report for fiscal 2025
- BioXcel Therapeutics, Inc. 8-K 2024BTAIQ 8-K 2024: current report for fiscal 2024
- BioXcel Therapeutics, Inc. 8-K 2023BTAIQ 8-K 2023: current report for fiscal 2023
- BioXcel Therapeutics, Inc. 8-K 2022BTAIQ 8-K 2022: current report for fiscal 2022
- BioXcel Therapeutics, Inc. DEF 14A 2026BTAIQ DEF 14A 2026: proxy statement for fiscal 2026
- BioXcel Therapeutics, Inc. DEF 14A 2025BTAIQ DEF 14A 2025: proxy statement for fiscal 2025
- BioXcel Therapeutics, Inc. DEF 14A 2024BTAIQ DEF 14A 2024: proxy statement for fiscal 2024
- BioXcel Therapeutics, Inc. DEF 14A 2023BTAIQ DEF 14A 2023: proxy statement for fiscal 2023
- BioXcel Therapeutics, Inc. DEF 14A 2022BTAIQ DEF 14A 2022: proxy statement for fiscal 2022
- BioXcel Therapeutics, Inc. Form 4 2026BTAIQ Form 4 2026: insider trading filing for fiscal 2026
- BioXcel Therapeutics, Inc. Form 4 2025BTAIQ Form 4 2025: insider trading filing for fiscal 2025
- BioXcel Therapeutics, Inc. Form 4 2024BTAIQ Form 4 2024: insider trading filing for fiscal 2024
- BioXcel Therapeutics, Inc. Form 4 2023BTAIQ Form 4 2023: insider trading filing for fiscal 2023
- BioXcel Therapeutics, Inc. Form 4 2022BTAIQ Form 4 2022: insider trading filing for fiscal 2022
- BioXcel Therapeutics, Inc. S-1 2026BTAIQ S-1 2026: registration statement for fiscal 2026
- BioXcel Therapeutics, Inc. S-1 2025BTAIQ S-1 2025: registration statement for fiscal 2025
- BioXcel Therapeutics, Inc. S-1 2024BTAIQ S-1 2024: registration statement for fiscal 2024
- BioXcel Therapeutics, Inc. S-1 2023BTAIQ S-1 2023: registration statement for fiscal 2023
- BioXcel Therapeutics, Inc. S-1 2022BTAIQ S-1 2022: registration statement for fiscal 2022
- BioXcel Therapeutics, Inc. 13F 2026BTAIQ 13F 2026: institutional holdings for fiscal 2026
- BioXcel Therapeutics, Inc. 13F 2025BTAIQ 13F 2025: institutional holdings for fiscal 2025
- BioXcel Therapeutics, Inc. 13F 2024BTAIQ 13F 2024: institutional holdings for fiscal 2024
- BioXcel Therapeutics, Inc. 13F 2023BTAIQ 13F 2023: institutional holdings for fiscal 2023
- BioXcel Therapeutics, Inc. 13F 2022BTAIQ 13F 2022: institutional holdings for fiscal 2022
More companies